Showing results (3781-3790 of 9,339) with videos related to
Sort By:
Pageof 934
Cancer Medicine|January 30, 2020
Thrombosis among 1537 patients with JAK2V617F -mutated myeloproliferative neoplasms: Risk factors and development of a predictive modelYuhui Zhang, Yuan Zhou, Yingshao Wang, et al.Cancer Medicine|March 7, 2020
Reliable blood cancer cells' telomere length evaluation by qPCRJoana Ropio, Alain Chebly, Jacky Ferrer, et al.Cancer Medicine|January 28, 2020
Serum Midkine is a clinical significant biomarker for colorectal cancer and associated with poor survivalMarius Kemper, Wiebke Hentschel, Julia-Kristin Graß, et al.Cancer Medicine|January 29, 2020
δ-Catenin regulates proliferation and apoptosis in renal cell carcinoma via promoting β-catenin nuclear localization and activating its downstream target genesLincheng Ju, Liping Shan, Bo Yin, et al.Cancer Medicine|March 7, 2016
High expression of TRF2, SOX10, and CD10 in circulating tumor microemboli detected in metastatic melanoma patients. A potential impact for the assessment of disease aggressivenessElodie Long, Marius Ilie, Coraline Bence, et al.Cancer Medicine|September 2, 2020
Microarray profiling of differentially expressed lncRNAs and mRNAs in lung adenocarcinomas and bioinformatics analysisFei He, Liping Huang, Qiuping Xu, et al.Cancer Medicine|September 2, 2020
Race modifies survival benefit of guideline-based treatment: Implications for reducing disparities in muscle invasive bladder cancerSamuel L Washington, Steven E Gregorich, Maxwell V Meng, et al.Cancer Medicine|September 2, 2020
LncRNA PITPNA-AS1 boosts the proliferation and migration of lung squamous cell carcinoma cells by recruiting TAF15 to stabilize HMGB3 mRNAPing Ren, Lei Xing, Xiaodong Hong, et al.Cancer Medicine|September 2, 2020
An observational study of drug utilization and associated outcomes among adult patients diagnosed with BRAF-mutant advanced melanoma treated with first-line anti-PD-1 monotherapies or BRAF/MEK inhibitors in a community-based oncology settingCharles L Cowey, Marley Boyd, Kathleen M Aguilar, et al.Cancer Medicine|September 3, 2020
Study and analysis of antitumor resistance mechanism of PD1/PD-L1 immune checkpoint blockerZhengyi Wang, Xiaoying WuPageof 934